{
    "Question": "IQVIA CES 2024 product highlight and specification",
    "Summary": "IQVIA\n\nCES 2024 Product Highlight\n\n- Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize trials for faster decision making and reduced risk.\n- Generate and disseminate real-world evidence for crucial clinical, regulatory, and commercial questions.\n- Elevate commercial models with precision and speed using AI-driven analytics and technology.\n- Orchestrate success across the complete compliance lifecycle with best-in-class services and solutions.\n- IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare.\n- IQVIA Decentralized Trials deliver purpose-built clinical services and technologies for engaging patients.\n- IQVIA Patient Experience Solutions powered by Apple personalize healthcare and connect patients to caregivers.",
    "Summary_cn": "IQVIA\n\nCES 2024产品亮点\n\n- 通过智能地连接数据、技术和分析，重新构想临床开发，优化试验以实现更快的决策和降低风险。\n- 生成和传播关键的临床、法规和商业问题的实际证据。\n- 使用人工智能驱动的分析和技术提升商业模型的精准度和速度。\n- 通过一流的服务和解决方案在整个合规生命周期中成功协同。\n- IQVIA AI连接正确的数据、技术和专业知识，满足医疗保健的独特需求。\n- IQVIA分散式试验提供专门为患者参与而设计的临床服务和技术。\n- IQVIA患者体验解决方案由Apple提供支持，个性化医疗护理并连接患者和护理人员。"
}